Company Timeline

Dr. B. Partha Saradhi Reddy founded Hetero, which has grown into a global leader in Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs).

Hetero entered the U.S. generics market through the acquisition of InvaGen Pharmaceuticals (which was later resold).

Camber Pharmaceuticals is established as the sales and marketing division for Hetero’s prescription products in the U.S.

To meet growing product and inventory demands, Camber moves to a state-of-the-art 60,000-square-foot headquarters and warehouse.

Hetero launches Ascent Pharmaceuticals to support product development in the U.S. Approximately 20% of Camber’s products are now manufactured by Ascent in Long Island, New York.

Camber Consumer Care is established to oversee the development and distribution of over-the-counter (OTC) products in the U.S.

To further increase domestic production capacity, Hetero launches Evaric Pharmaceuticals, a second U.S. manufacturing facility in New York.

Hetero forms XLCare Pharmaceuticals to meet the unique requirements of U.S. government accounts.

Camber moves into a significantly larger facility in New Jersey, spanning over 200,000 square feet, to support its rapid growth bringing our total capacity to 350,000 square feet in the US.

Camber Specialty is established to focus on specialty pharmaceutical products, including generic injectable medications and oncology drugs.

In 2024, Camber had launched 36 new generic products, setting a new organizational record.